Viewing Study NCT04002934

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-01-10 @ 10:07 AM
Study NCT ID: NCT04002934
Status: COMPLETED
Last Update Posted: 2025-06-08
First Post: 2019-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
Sponsor: Riley Bove, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
None Multiple Sclerosis, Relapsing-Remitting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MS View
None RRMS View
None Remyelination View
None Repair View
None Multiple Sclerosis View
None SERM View
None Estrogen View
None BZA View
None Bazedoxifene View
None Myelin Repair View
None Conbriza View